Novavax to Host Conference Call to Discuss Second Quarter 2014 Financial Results on August 6, 2014
July 30 2014 - 4:13PM
ROCKVILLE, Md., July 30, 2014 (GLOBE NEWSWIRE) --
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical
company focused on the discovery, development and commercialization
of recombinant nanoparticle vaccines and adjuvants, announced today
that it will report its financial results for the second quarter of
2014 on Wednesday, August 6, 2014, after market close.
In addition, management will host a conference
call, to discuss the quarterly financial results and provide an
update on corporate activities. Conference call details are as
follows:
| Date: |
August 6,
2014 |
| Time: |
4:30 PM US
eastern time |
| Dial-in
number: |
1 (877)
212-6076 (domestic) or 1 (707) 287-9331 (international) |
| Via
Web: |
www.novavax.com |
Conference call Replay:
| Dates: |
Starting at
6:31pm on August 6, 2014 until midnight October 6, 2014 |
| Dial-in
number: |
1 (855)
859-2056 (domestic) or 1 (404) 537-3406 (international) |
|
Passcode: |
82216889 |
|
Via-Web: |
www.novavax.com, "Investor Info"/"Events" |
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
biopharmaceutical company creating novel vaccines and vaccine
adjuvants to address a broad range of infectious diseases
worldwide. Using innovative proprietary recombinant protein
nanoparticle vaccine technology, the company produces vaccine
candidates to efficiently and effectively respond to both known and
newly emergent diseases. Additional information about Novavax is
available on the company's website, novavax.com.
CONTACT: Barclay Phillips
SVP, Chief Financial Officer and Treasurer
Novavax, Inc.
240-268-2000
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
HUG#1844196
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024
